Ron Nardi

Dr. Nardi has broad therapeutic experience as a Research and Development Executive having spent more than 35 years involved across the spectrum of drug discovery and drug development responsibilities from target identification through clinical pharmacology, clinical development and global regulatory affairs including multiple drug approvals in several therapeutic categories. Prior to his experience at Innova Therapeutics he served in various senior positions at Scioderm, the International Partnership for Microbicides, and Ferring Pharmaceuticals. Earlier in his career he managed discovery research activities in several large pharmaceutical companies including Glaxo and Warner-Lambert Pharmaceutical Research. Dr. Nardi has a Ph.D in pharmacology and toxicology.

​​Dr. Nardi’s experience in multiple therapeutic categories includes cardiovascular diseases (CAD and heart failure), gastrointestinal disease (IBD, ulcer disease, GERD), endocrinology (infertility, brain-gut peptides) and oncology (prostate, sarcomas).